Aging isn’t a single process — it’s a small set of interlocking cellular systems that drift out of balance over time. The longevity field is built on the proposition that those systems can be measured and targeted directly. Regenerative medicine is one of the more concrete tools in that toolkit.
By Jed Ryan, Founder and CEO · Reviewed by Adas Darinskas, PhD, Chief Science Officer · Published · Last reviewed
Aging isn’t inevitable in the way it looks from the outside. The visible decline — reduced energy, slower recovery, cognitive softening, accumulated weight, declining mobility — is the surface of a small number of underlying biological processes. Geroscience has spent two decades cataloguing them, and most cluster under what researchers now call the “hallmarks of aging.”
The cluster we work with covers:
Each of these is a measurable cellular process, not a vague descriptor. And each is something regenerative medicine has at least one direct mechanism to address.
The hallmarks of aging are interrelated — intervention on one usually affects the others. A useful longevity protocol targets several at once.
Standard wellness advice (sleep, nutrition, exercise) addresses these systems indirectly and slowly. Regenerative medicine works on them at the cellular level, with effects measurable in months rather than decades.
Four primary mechanisms do most of the work in longevity protocols.
Longevity work is iterative. Most patients run protocols at 6–12 month intervals, with biomarker tracking (epigenetic age, inflammatory markers, mitochondrial function) to evaluate response over time.
Longevity protocols are designed individually by Dr. Adas Darinskas based on baseline biomarkers, age, family history, and existing health context. The four building blocks below are the ones most often deployed.
An advanced class of mesenchymal stem cells with a stress-enduring property. Systemic IV delivery supports declining endogenous stem cell pools, contributes paracrine signaling to aging tissue, and modulates the inflammatory environment that drives inflammaging. The cellular foundation of any serious longevity protocol.
Learn moreStem-cell-derived nanoparticles that distribute the regenerative cargo systemically. Smaller and more diffusible than the cells themselves, they reach tissue beds — including the brain — that are harder to access with cellular therapy alone. Often layered with MSCs in longevity protocols.
Learn moreA targeted longevity peptide stack: Epitalon for telomerase support and pineal-axis function; MOTS-c and 5-Amino-1MQ for mitochondrial and metabolic biology; GHK-Cu for tissue and skin regeneration; Cerebrolysin for cognitive support. Stacked selectively per case — not all patients use all peptides.
Learn moreNAD+ infusions are foundational in longevity work — mitochondrial cofactor restoration that no oral supplement matches in concentration. Layered with high-dose vitamin C, glutathione, and amino-acid infusions to support the broader metabolic environment in which the cellular work has to operate.
Learn moreLongevity protocols are typically run as a 1–2 week in-clinic phase followed by an extended at-home peptide cycle, with follow-up rounds at defined intervals as biomarker data accumulates. We track outcomes; we don’t guess at them.
Strong Craft Regen maintains a continuously updated repository of peer-reviewed research on regenerative medicine — the studies, mechanisms, and ongoing investigations that inform every protocol we coordinate.
Explore the research →